1. Home
  2. RLMD vs VNCE Comparison

RLMD vs VNCE Comparison

Compare RLMD & VNCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • VNCE
  • Stock Information
  • Founded
  • RLMD 2004
  • VNCE 2002
  • Country
  • RLMD United States
  • VNCE United States
  • Employees
  • RLMD N/A
  • VNCE N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • VNCE Clothing/Shoe/Accessory Stores
  • Sector
  • RLMD Health Care
  • VNCE Consumer Discretionary
  • Exchange
  • RLMD Nasdaq
  • VNCE Nasdaq
  • Market Cap
  • RLMD 20.3M
  • VNCE 20.2M
  • IPO Year
  • RLMD N/A
  • VNCE 2013
  • Fundamental
  • Price
  • RLMD $0.63
  • VNCE $1.53
  • Analyst Decision
  • RLMD Buy
  • VNCE Strong Buy
  • Analyst Count
  • RLMD 3
  • VNCE 4
  • Target Price
  • RLMD $5.00
  • VNCE $4.13
  • AVG Volume (30 Days)
  • RLMD 142.9K
  • VNCE 21.1K
  • Earning Date
  • RLMD 08-07-2025
  • VNCE 09-15-2025
  • Dividend Yield
  • RLMD N/A
  • VNCE N/A
  • EPS Growth
  • RLMD N/A
  • VNCE N/A
  • EPS
  • RLMD N/A
  • VNCE N/A
  • Revenue
  • RLMD N/A
  • VNCE $292,214,000.00
  • Revenue This Year
  • RLMD N/A
  • VNCE $1.93
  • Revenue Next Year
  • RLMD N/A
  • VNCE $4.91
  • P/E Ratio
  • RLMD N/A
  • VNCE N/A
  • Revenue Growth
  • RLMD N/A
  • VNCE 1.46
  • 52 Week Low
  • RLMD $0.24
  • VNCE $1.02
  • 52 Week High
  • RLMD $3.98
  • VNCE $6.89
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 51.70
  • VNCE 51.33
  • Support Level
  • RLMD $0.59
  • VNCE $1.43
  • Resistance Level
  • RLMD $0.64
  • VNCE $1.50
  • Average True Range (ATR)
  • RLMD 0.05
  • VNCE 0.09
  • MACD
  • RLMD 0.00
  • VNCE -0.01
  • Stochastic Oscillator
  • RLMD 55.00
  • VNCE 70.00

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About VNCE Vince Holding Corp.

Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.

Share on Social Networks: